David Robbins

Genomind

Genomind is a leading precision health company focused on optimizing the treatment experience for individuals and healthcare providers through actionable genetic insights and innovative health technology. Since its founding, Genomind has expanded beyond its flagship of pharmacogenetic testing to develop a comprehensive portfolio of precision health services for individual and population-level patient care. Built on the foundation of compassionate care and clinical expertise, Genomind is empowering a more targeted and personalized approach to medication management, and a new standard of care. Genomind's Pharmacogenetic Test is an industry-leading prescription genetic test that equips healthcare professionals with tools they need to more quickly identify a personalized treatment plan for their patients. Genomind offers more comprehensive genetic guidance, superior speed and accuracy, state-of-the-art digital tools, and scheduled PhD and PharmD expert consultations. This test is available via clinician order only. Genomind® Mental Health Map™ is the first-ever genetic test available direct-to-consumer designed specifically for mental health and wellness. It provides powerful new insights and actions through reports in the 7 Core Genetic Mental Health Capabilities™ by analyzing genetic makeup across 35 genes, 38 genetic variants, 21 genetic mechanisms, and 59 mental health predispositions. Included is a free consult to help individuals better take advantage of their results. This test does not inform on medications nor require clinician order. If you are a patient who is interested in our testing, or a clinician interested in using these tools in your practice, please contact us at 877-895-8658 or customerservice@genomind.com. Learn more at www.genomind.com.